FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 600 mg/3 L | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 3000 mg/3 L | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 1500 mg/3 L | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 3000 mg/3 L | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 600 mg/3 L | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 600 mg/3 L | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 1500 mg/3 L | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 30 g/3 L | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 25 g/500 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 30 g/3 L | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 75 g/1500 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 30 g/3 L | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Labetalol Hydrochloride | 15 g/3 L | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Lidocaine Hydrochloride | 2334 mg/2000 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Methadone Hydrochloride | 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Phenylephrine Hydrochloride | .08 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Phenylephrine Hydrochloride | .1 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Phenylephrine Hydrochloride | .1 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Rocuronium Bromide | 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Succinylcholine Chloride | 20 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Succinylcholine Chloride | 20 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ephedrine Sulfate | 5 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | "vasopressin, Unspecified" | 20 U | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ephedrine Sulfate | 5 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ephedrine Sulfate | 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .02 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .02 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .025 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .05 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .05 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Isoproterenol Hydrochloride | .004 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ketamine Hydrochloride | 2 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ketamine Hydrochloride | 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ketamine Hydrochloride | 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Lidocaine Hydrochloride | 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Lidocaine Hydrochloride | 20 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-731 | 70004-731-30 | Magnesium Sulfate Heptahydrate | 2 g | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-411 | 70004-411-56 | Midazolam Hydrochloride | 1 mg/1 mL | 2021-2 | valid | 2026-11-12 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-411 | 70004-411-59 | Midazolam Hydrochloride | 1 mg/1 mL | 2021-2 | valid | 2026-11-12 |